Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,847
datasets available to search
ShareScore release 0.9.0
Dataset results
1,847 results for “Psoriasis”
A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03875482. IPD Sharing: YES. Countries: 2. Publications: 1.
A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT05364554. IPD Sharing: YES. Countries: 10. Publications: 2.
Fluphenazine Decanoate for Psoriasis
ClinicalTrials.gov study NCT00356200. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3
ClinicalTrials.gov study NCT00789880. IPD Sharing: YES. Countries: 1. Publications: 2.
Mechanism of Action Study for Psoriasis
ClinicalTrials.gov study NCT00932113. IPD Sharing: NO. Countries: 1. Publications: 7.
LEO 90100 in the Treatment of Psoriasis Vulgaris
ClinicalTrials.gov study NCT01536938. IPD Sharing: NO. Countries: 1. Publications: 2.
Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT05335356. IPD Sharing: NO. Countries: 1. Publications: 2.
A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT03384745. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
ClinicalTrials.gov study NCT02969018. IPD Sharing: YES. Countries: 3. Publications: 3.
Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT02785185. IPD Sharing: YES. Countries: 1. Publications: 1.
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03611751. IPD Sharing: Not stated. Countries: 16. Publications: 6.
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
ClinicalTrials.gov study NCT03556202. IPD Sharing: YES. Countries: 19. Publications: 1.
Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)
ClinicalTrials.gov study NCT02346240. IPD Sharing: Not stated. Countries: 9. Publications: 3.
Rimegepant in Moderate Plaque-type Psoriasis
ClinicalTrials.gov study NCT04629950. IPD Sharing: NO. Countries: 1. Publications: 15.
LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris
ClinicalTrials.gov study NCT02899962. IPD Sharing: NO. Countries: 6. Publications: 3.
A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis
ClinicalTrials.gov study NCT00820950. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
ClinicalTrials.gov study NCT01147874. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis
ClinicalTrials.gov study NCT03850483. IPD Sharing: YES. Countries: 10. Publications: 2.
Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis
ClinicalTrials.gov study NCT04664153. IPD Sharing: YES. Countries: 4. Publications: 1.
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT02201524. IPD Sharing: Not stated. Countries: 2. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.